I assume it's that doctors would need to disclose that they are using a clinical model that relies on HeraCare and they derive a financial benefit from its use.
Surely given it offers better clinical outcomes that simply disclosing it would not be too problematic.
- Forums
- ASX - By Stock
- HMD
- Ann: Appendix 4D and Half Year Report
Ann: Appendix 4D and Half Year Report, page-16
-
- There are more pages in this discussion • 145 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HMD (ASX) to my watchlist
|
|||||
Last
2.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.56M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 310082 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.3¢ | 249436 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 310082 | 0.021 |
3 | 1079500 | 0.020 |
1 | 998971 | 0.018 |
1 | 1000000 | 0.017 |
3 | 1242548 | 0.015 |
Price($) | Vol. | No. |
---|---|---|
0.023 | 249436 | 1 |
0.024 | 200000 | 1 |
0.025 | 72222 | 1 |
0.026 | 156429 | 1 |
0.027 | 150000 | 1 |
Last trade - 10.09am 12/09/2024 (20 minute delay) ? |
Featured News
HMD (ASX) Chart |
Day chart unavailable